相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment
M. Rosenblum et al.
BIOMETRIKA (2011)
Pharmacogenetics in randomized controlled trials: considerations for trial design
Frederieke H. van der Baan et al.
PHARMACOGENOMICS (2011)
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis
Dirk Bassler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Adaptive patient enrichment designs in therapeutic trials
Sue-Jane Wang et al.
BIOMETRICAL JOURNAL (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
Fred R. Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A regulatory view on adaptive/flexible clinical trial design
H. M. James Hung et al.
BIOMETRICAL JOURNAL (2006)
Adaptive designs in clinical drug development - An Executive Summary of the PhRMA Working Group
Paul Gallo et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2006)
A review of methods for futility stopping based on conditional power
JM Lachin
STATISTICS IN MEDICINE (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Early stopping in clinical trials and epidemiologic studies for futility: Conditional power versus sequential analysis
I van der Tweel et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia
FJ Giles et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Efficacy of St. John's Wort extract WS 5570 in major depression: A double-blind, placebo-controlled trial
Y Lecrubier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
分享论文
